Plasma lipids and prolactin in patients with breast cancer
about
Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan.Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).Serum lipids, lipoproteins and sex-hormone binding globulin in breast cancer.Alterations of serum cholesterol and serum lipoprotein in breast cancer of womenPlasma lipids in premenopausal women with mammographic dysplasia.Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients.Cholesterol transport and regulation in the mammary gland.Oral contraceptives and breast cancer. A review.Low high-density lipoprotein cholesterol may signal breast cancer risk: recent findings and new hypotheses.Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.Metabolic Syndrome and Breast Cancer Risk.Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk.Associations between breast cancer, plasma triglycerides, and cholesterol.Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease.Association of Dyslipidemia, Increased Insulin Resistance, and Serum CA 15-3 with Increased Risk of Breast Cancer in Urban Areas of North and Central India.
P2860
Q34000430-332C4415-B439-4064-9468-3E62D3B78FEAQ34730815-ED9CC31E-A830-483F-99AC-CF8B66042496Q35103289-A4C3F374-59AB-4A99-BC71-2A415D6DA290Q35628081-CBA9245E-6DFE-4EB9-B1E2-EDFF26FB779BQ36081293-A523360C-522B-417C-BDEF-2A0016AD6683Q36264249-B9204D08-15F6-4673-B43A-45AF91820C05Q36265788-CDB62EAC-7982-442D-AF56-6FC7E3D652DEQ36467747-75C247E6-E063-46AB-BF15-9885C9C7ED77Q37136008-3DA3215C-03DD-4EB1-AFEF-C869201CF993Q38186620-12067A49-DC3B-4AC7-9114-75346380819EQ38754835-D371C49E-2A31-456F-9A27-E37CD74078DFQ40208562-922E33B2-8C74-4512-8B5F-D1BB59989A60Q45006133-3F1D7899-A489-44CC-AF70-F575B5C63FA1Q49623072-ADFFB221-E806-487B-B937-E260848B3548Q51577587-30448899-9E15-4B37-9332-CB557FCA6797Q51612656-E19EAA34-B1A1-4EFA-A461-C1958B2E0DA0Q52414144-0F59CFEC-243A-4DE6-A81F-C97279A478D0Q55360606-82460EFE-2CDA-4652-ABAF-17B73A27686C
P2860
Plasma lipids and prolactin in patients with breast cancer
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Plasma lipids and prolactin in patients with breast cancer
@ast
Plasma lipids and prolactin in patients with breast cancer
@en
type
label
Plasma lipids and prolactin in patients with breast cancer
@ast
Plasma lipids and prolactin in patients with breast cancer
@en
prefLabel
Plasma lipids and prolactin in patients with breast cancer
@ast
Plasma lipids and prolactin in patients with breast cancer
@en
P2093
P2860
P356
P1476
Plasma lipids and prolactin in patients with breast cancer
@en
P2093
Boulter PS
Dickerson JW
Williams CM
P2860
P2888
P304
P356
10.1038/BJC.1986.195
P407
P577
1986-09-01T00:00:00Z